GETINGE B

Overview

Getinge AB is a Swedish medical-technology company serving hospitals and life-science institutions. Its business spans acute-care and cardiovascular therapies, surgical workflows, and life-science products, including solutions for operating rooms, sterile reprocessing, pharmaceutical production, and laboratory research.[1][2] The company describes its purpose as “making life-saving technology accessible to more people.” [3]

Getinge reports operations in 40 countries and sales in more than 135 countries, with approximately 12,000 employees.[1] For FY2025, net sales were SEK 34,969 million.[4] Founded in Getinge, Sweden, in 1904, the company entered medical technology in 1932 with sterilizers.[5] [4]+4

Products & services

Getinge’s Acute Care Therapies products include the Servo-u mechanical ventilator, which supports invasive and non-invasive ventilation, High Flow, and lung-protection tools such as NAVA; and the Cardiohelp portable extracorporeal life-support system for respiratory or circulatory support, including during patient transport. Cardiohelp has a 5.7-inch touchscreen and at least 90 minutes of battery operation when fully charged.[6][7] Acute Care Therapies accounted for 53.4% of Getinge’s 2025 net sales.[8]

Surgical Workflows includes the Maquet Magnus modular operating table system, with a height range of 535–1,235 mm, inclination up to 80°, tilt up to 45°, and patient capacity up to 250 kg (or 380 kg in specified circumstances). Its sterile-reprocessing products include the GSS67H hospital steam sterilizer, which Getinge says can offer process times up to 30% faster and load capacity up to 33% greater than comparable sterilizers.[9][10] Surgical Workflows represented 33.7% of 2025 net sales.[8]

Life Science supplies pharmaceutical-production and research-laboratory equipment, including the customizable Applikon AppliFlex ST single-use stirred-tank bioreactor for microbial and cell-culture work, available in 500 mL, 3 L and 15 L sizes, as well as cGMP stainless-steel bioreactors and laboratory sterilization systems.[11]+2 Life Science accounted for 12.9% of 2025 net sales.[8] Services include preventive maintenance, repairs and original parts, digital lifecycle and maintenance services, financial services, planning and design, project implementation, and education and training.[14] [8]+8

Geographic presence

Getinge has offices in 39 countries, serves customers in more than 135 markets, and operates manufacturing sites in France, China, Germany, Poland, Sweden, Turkey, the Netherlands, the UK and the US.[15][16]

In 2025, 98.1% of net sales were international. The US was the largest market listed for each business area: 48.0% of Acute Care Therapies sales, 34.6% of Life Science sales and 30.9% of Surgical Workflows sales. These are business-area shares, not a consolidated geographic revenue breakdown.[17][18]

Getinge reported 11,788 employees in 2025: 6,874 in EMEA (58.3%), 3,337 in the Americas (28.3%) and 1,577 in APAC (13.4%). Sweden accounted for 1,314 employees and the US for 3,053.[19] [17]+4

Business segments

Getinge reports three business areas: Acute Care Therapies, Life Science, and Surgical Workflows. In FY2025, net sales were SEK 18,675m for Acute Care Therapies (about 53.4% of group sales), SEK 4,498m for Life Science (12.9%), and SEK 11,796m for Surgical Workflows (33.7%), from total group sales of SEK 34,969m.[4]

Acute Care Therapies focuses on life-support solutions for acute conditions, including cardiovascular procedures, organ handling for transplantation, and intensive-care products and therapies. Life Science serves pharmaceutical production and research laboratories. Surgical Workflows focuses on operating-room solutions and surgical workflow equipment; the product portfolio also includes sterile reprocessing.[20][21]

For the latest reported period, January–June 2026, the same three segments accounted for approximately 54.1% (SEK 8,565m), 13.3% (SEK 2,104m), and 32.6% (SEK 5,155m) of group sales, respectively. These are half-year contributions, not full-year estimates.[22] [4]+3

Company history

Getinge traces its origins to 1904, when Olander Larsson established an agricultural-equipment business in Getinge, Sweden. In 1932, the company began producing steam sterilizers, marking its expansion into healthcare equipment; it was listed on the Stockholm Stock Exchange in 1993.[5]

A series of acquisitions broadened its healthcare businesses: Arjo in 1995 added patient-care products, Maquet in 2000 expanded its surgical offering, and acquisitions in 2003 and 2008 added cardiac-surgery, ventilation, anesthesia and cardiovascular capabilities.[23][24] In 2017, Getinge distributed its Patient & Post-Acute Care business to shareholders as the separately listed Arjo; Mattias Perjos became Getinge’s President and CEO that year.[25][26] Acquisitions in 2023–24 added businesses in infection control, bioprocessing and organ transport.[24] [23]+4

Sources

• www.getinge.com[1]
• www.getinge.com[2]
• www.getinge.com[3]
• GETINGE B — Full financial report (2025 Y)
  7 citations

  [4][8][17][18][19][23][24]
• www.getinge.com[5]
• www.getinge.com[6]
• www.getinge.com[7]
• www.getinge.com[9]
• www.getinge.com[10]
• www.getinge.com[11]
• www.getinge.com[12]
• www.getinge.com[13]
• www.getinge.com[14]
• www.getinge.com[15]
• www.getinge.com[16]
• www.getinge.com[20]
• www.getinge.com[21]
• GETINGE B — Partial financial report (2026 Q 2)[22]
• www.getinge.com[25]
• www.getinge.com[26]